These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7930684)

  • 1. Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes.
    Nestle FO; Mitra RS; Bennett CF; Chan H; Nickoloff BJ
    J Invest Dermatol; 1994 Oct; 103(4):569-75. PubMed ID: 7930684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects.
    Hertl M; Neckers LM; Katz SI
    J Invest Dermatol; 1995 May; 104(5):813-8. PubMed ID: 7738361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
    Miele ME; Bennett CF; Miller BE; Welch DR
    Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.
    Chiang MY; Chan H; Zounes MA; Freier SM; Lima WF; Bennett CF
    J Biol Chem; 1991 Sep; 266(27):18162-71. PubMed ID: 1680858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides.
    Bennett CF; Condon TP; Grimm S; Chan H; Chiang MY
    J Immunol; 1994 Apr; 152(7):3530-40. PubMed ID: 7511650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
    Bennett CF; Chiang MY; Chan H; Shoemaker JE; Mirabelli CK
    Mol Pharmacol; 1992 Jun; 41(6):1023-33. PubMed ID: 1352033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
    Bennett CF; Mirejovsky D; Crooke RM; Tsai YJ; Felgner J; Sridhar CN; Wheeler CJ; Felgner PL
    J Drug Target; 1998; 5(3):149-62. PubMed ID: 9606005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.
    Dean NM; McKay R; Condon TP; Bennett CF
    J Biol Chem; 1994 Jun; 269(23):16416-24. PubMed ID: 7911467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
    Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes.
    Ikeda M; Schroeder KK; Mosher LB; Woods CW; Akeson AL
    J Invest Dermatol; 1994 Dec; 103(6):791-6. PubMed ID: 7798616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression.
    Trefzer U; Brockhaus M; Loetscher H; Parlow F; Kapp A; Schöpf E; Krutmann J
    J Invest Dermatol; 1991 Nov; 97(5):911-6. PubMed ID: 1680933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat.
    Vemuganti R; Dempsey RJ; Bowen KK
    Stroke; 2004 Jan; 35(1):179-84. PubMed ID: 14657453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic therapy for transplant vascular sclerosis.
    Bennett CF; Stepkowski SM
    Transpl Immunol; 1997 Dec; 5(4):299-302. PubMed ID: 9504151
    [No Abstract]   [Full Text] [Related]  

  • 14. Cationic lipids employed for antisense oligodeoxynucleotide transport may inhibit vascular cell adhesion molecule-1 expression in human endothelial cells: a word of caution.
    Maus U; Rosseau S; Mandrakas N; Schlingensiepen R; Maus R; Muth H; Grimminger F; Seeger W; Lohmeyer J
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):71-80. PubMed ID: 10192291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-gamma-treated keratinocytes and keratinocyte cell lines.
    Wakita H; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1995 Oct; 105(4):536-42. PubMed ID: 7561155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.
    Griffiths CE; Voorhees JJ; Nickoloff BJ
    J Am Acad Dermatol; 1989 Apr; 20(4):617-29. PubMed ID: 2497153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease.
    Yacyshyn BR; Bowen-Yacyshyn MB; Jewell L; Tami JA; Bennett CF; Kisner DL; Shanahan WR
    Gastroenterology; 1998 Jun; 114(6):1133-42. PubMed ID: 9609749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis.
    Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL
    Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.
    Henry SP; Templin MV; Gillett N; Rojko J; Levin AA
    Toxicol Pathol; 1999; 27(1):95-100. PubMed ID: 10367680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the biological activity of anti-ICAM-1 oligonucleotides complexed to non-viral carriers.
    Lucas B; Van Rompaey E; Remaut K; Sanders N; De Smedt SC; Demeester J
    J Control Release; 2004 Apr; 96(1):207-19. PubMed ID: 15063042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.